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Abstract  
Background: Personalised nutrition (PN) may promote public health. PN involves dietary 
advice based on individual characteristics of end users and can for example be based on 
lifestyle, blood and/or DNA profiling. Currently PN is not refunded by most health insurance 
or health care plans. Improved public health is contingent on individual consumers being 
willing to pay for the service.  
Methods: A survey with a representative sample from the general population was 
conducted  in eight European countries (N=8233). Participants reported their willingness to 
pay (WTP) for PN based on lifestyle information, lifestyle and blood information, and lifestyle 
and DNA information. WTP was elicited by contingent valuation with the price of a standard, 
non-personalised nutrition advice used as reference. 
 Results: About 30% of participants reported being willing to pay more for personalised 
nutrition than for non-personalised nutrition advice. They were  on average prepared to pay 
about 150% of the reference price of a standard, non-personalised advice, with some 
differences related to socio-demographic factors.  
Conclusion: There is a potential market for PN compared to non-PN advice, particularly 
among men on higher incomes. These findings raise questions to what extent personalized 
nutrition can be left to the market or should be incorporated into public health programs. 
 
Keywords: Personalised nutrition, Willingness to pay, Nutrition services, Preventive 
medicine; Food4Me 
Key points:  
• There is a potential market for personalised-nutrition advice in the EU 
• The majority of people is not willing to pay for personalised- nutrition advice 
• Willingness to pay for personalisation based on DNA sampling is not higher than 
for personalisation based on lifestyle or blood data.  
• Large scale adoption of personalised nutrition is likely to require inclusion in 
national health services 
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Introduction 
Current advances in nutrition science and more specifically in nutrigenomics indicate that 
more specific information about an individual could be used to develop personalised nutrition 
(PN) advice that is tailored to individual needs(1). Increased personalisation requires more 
information about an individual e.g. a blood sample to assess cholesterol levels, in order to 
suggest specific dietary recommendations. Genetic analysis can be applied to predict 
potential future nutritional needs, or to investigate how specific nutrients contribute to the 
healthiness of an individual’s diet.  
Currently, most health insurance companies or health service providers, such as the NHS, 
or health care insurances do not refund the cost of PN advice. Therefore, adoption depends 
on consumers’ willingness to pay (WTP) for commercial PN advice. Although various 
businesses have marketed PN as a viable opportunity(2), there is no clear idea about how 
much consumers are willing to spend on PN advice(3).  
This paper presents results from a survey that assessed people’s WTP for PN based on 
three different levels of personal information: i) lifestyle (food consumption and physical 
exercise pattern); ii) lifestyle and phenotype (from analysis of a blood sample); lifestyle and 
genotype (from DNA testing using a saliva sample). Comparisons regarding WTP were made 
between countries, gender, age groups, and income and education levels. 
Methods  
A survey was conducted in November and December 2012 in representative samples 
from the general population in eight EU countries1 as part of a larger study on PN(4). Data 
reported here have not been published previously. 
WTP was measured as a two-step contingent valuation. Participants were first asked 
whether they would be willing to pay a price equal to that of standard, non-PN advice 
provided by a qualified dietitian. Those who reported a WTP of at least this reference price 
were provided with a continuous scale of which the lower-end represented the reference 
price, and the higher end being five times the reference price. Participants who reported to 
be not willing to pay the reference price were provided with a scale that ranged from 0 to the 
reference price.  
                                               
1
 Greece, Spain, Germany, Ireland, Netherlands, UK. Poland and Norway 
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Based on the price of general dietary advice in the Netherlands (about 100€),  reference 
prices were calculated for all participating countries using the Eurostat Comparative Price 
Level index of 2011(5). To check whether the calculated reference prices resembled dietary 
advice prices of the participating countries, the reference price of each country was 
compared to the price of a national Weight Watchers2 dietary service. To allow comparability 
across countries, the reported WTPs were expressed as percentages of the reference prices. 
Each participant scored WTP for three levels of personal information: lifestyle (about daily 
diets and exercise); lifestyle and phenotype (with additional information from  blood chemistry 
information); and,  lifestyle and genotype (with additional information from DNA testing using 
a saliva sample). The order of WTP scoring was randomized.  
WTP data were coded into three classes: (1) Nothing: WTP=0; (2) Low: 0.< WTP < 
reference price; (3) High: WTP ≥ reference price. In addition, age, gender, income 
(compared to the modal income of country of residence3), education (Low: 12 or fewer years 
of schooling, including kindergarten; Medium: 12-16 years education; High: degree level) 
were recorded.Of the 8233 participants, 919 did not disclose income. These participants 
were omitted from analyses that included income as determinant.. Distributions of 
participants across the WTP classes were cross-tabulated with these demographics and 
tested using χ2. In addition, factorial ANOVAs were conducted testing the main effects of the 
sociodemographic on WTP, for the Lower and Higher WTP class4 and each level of personal 
information. 
Results 
A total of 8233 participants from the representative survey completed the questionnaire. 
Gender distribution was about equal (50.6% male). Twenty-two percent of participants were 
aged between 18 and 29 years; 23% between 30 and 39 years; 35% between 40 and 54 
years; and 20% between 55 and 65 years. Twenty-nine percent reported low education level; 
39% had completed medium level education; and, 32% had completed higher education. 
Income distribution peaked (as expected) around the modal income of each country,  with 
49.3% (3605) of those willing to disclose income information, earning between 0.5 and 1.5 
times modal income.  
                                               
2
 Weight Watchers is an international company that offers various products and services to assist weight loss and 
maintenance 
3
 Modal incomes at the time of data collection were: Germany: 25,000€ ; Spain: 22,000€; Greece: 20,000€; 
Ireland: 24,000 €; Netherlands: 30,000€; United Kingdom: 22,000₤; Poland: 50,000 Złoty; Norway: 322,000 
kroner, Portuguese participants did not fill out this question. 
4
 For the Nothing WTP class, an ANOVA would be meaningless since all participants in this class scored a WTP 
equal to 0. 
Page 4 of 13
http://mc.manuscriptcentral.com/ejph
Manuscripts submitted to European Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 
5 
 
Average WTP as percentage of the reference price provided is reported in Table 1. 
-------------------------------------- 
TABLE 1 ABOUT HERE 
-------------------------------------- 
A minority of the participants (about 30% see Table 2) showed a higher WTP for PN 
advice than the reference price of standard, non-PN. About half showed a WTP less than the 
reference price. The remaining participants (about 20%; Table 2) reported not being willing to 
pay anything for PN advice. WTP-class percentages differed between the three levels of 
information (Friedman X2(2)=106.98, N=8233, p<0.001). For lifestyle-based nutrition advice, 
relatively fewer participants had a WTP above the reference price and more a WTP below 
the reference price. For lifestyle and phenotype information, more participants were willing to 
pay more, and fewer did not want to pay anything. For lifestyle and phenotype analysis and 
lifestyle and genotype analysis, more than expected were willing to pay nothing, while fewer 
than expected were willing to pay a lower price (Table 2).  
The effects of gender, age, income, education level and country on WTP class 
membership and mean WTP per WTP class were tested. Figure 1 gives an overview of the 
percentages, means, standard deviations, and medians. Tests statistics are provided in 
Table 3.  
-------------------------------------- 
TABLE 2 ABOUT HERE 
-------------------------------------- 
-------------------------------------- 
TABLE 3 ABOUT HERE 
-------------------------------------- 
-------------------------------------- 
FIGURE 1 ABOUT HERE 
-------------------------------------- 
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Discussion 
Only about a third of the participants showed WTP PN higher than the reference price of 
standard, non-PN advice. They were on average willing to pay a price of 40% and 50% of 
higher than the reference price. The additional amount people were willing to pay for the 
more advanced forms of personalisation (based on phenotype or genotype) was very small 
compared to what participants were willing to pay for lifestyle-only based PN advice. This 
aligns with previous research(6), where it was reported that people did not perceive 
additional benefits accruing from more medicalised personal data.  
A sizable minority (20%) indicated that they are willing to pay nothing for PN. While this 
may imply these participants and those with a WTP considerably lower than the price of 
standard, non-PN advice, reject the idea of PN altogether this is not necessarily the case. 
Current concerns about data privacy, lack of confidence in the efficacy of PN, or distrust in  
the motivations of the service providers(6) may have, reduced their current WTP. It is also 
impossible to rule out that there was a group of people not willing to pay the reference price 
for the non-PN service, which may have reduced WTP for PN services.5 Another group may 
have consisted of people who were potentially interested in adopting a PN advice but were 
opposed to paying for healthcare(8). Finally there may have been a group of people for 
whom the personalized nutrition remained abstract and hypothetical and therefore indicated 
a low WTP.  
There were some differences in WTP between countries. For example, participants from 
the Netherlands and the UK were most often in the nothing and lower class and those in the 
lower class wanted to pay less than the reference  scored among those with the lowest WTP, 
while those with WTP more than the reference price were among those with the highest 
WTP. This may have to do with the availability of relatively inexpensive basic healthcare 
(Netherlands), or free of direct charge basic healthcare (UK), while non-standard care is 
something for which they have to pay.  
There were more males than females reporting a WTP of nothing. Whereas males with 
WTP lower than the reference value showed means lower than female participants, males 
with a WTP higher than the reference value had a higher WTP than females. This suggests 
that male participants, once committed to PN, have a higher WTP than females.  
 Participants  in the highest income classes reported the highest WTP for PN. This 
suggests that commercial introduction of personalized nutrition services would benefit higher 
                                               
5
 A much larger proportion (about 60%) of participants in a proof of principle trial in the same countries completed 
the same survey (7) and were willing to pay a higher price for a PN service than for a non-PN service (data not 
shown), indicating that motivation to engage with nutrition advice may be a central driver for adoption. 7. Panzone L, van der 
Lans I, Stewart-Knox B, Poínhos R, Fischer A, Kuznesof S, et al. Effects of trial participation on beliefs, attitudes, and adoption intention regarding to adopt personalised nutrition: a propensity score matching approach. submitted. 
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socio-economic classes most, while it is generally accepted that these groups in the 
population already have better health(9). The higher WTP may in part be related to higher 
income classes having more awareness of health issues, but it may also relate to the 
availability of resources (money) to engage in nutrition services. This raises important ethical 
questions to whether personalised nutrition should also be accessible to lower income 
classes that may need it more than those with high income. Considering the low WTP of 
these income classes other ways could be explored, for example, through employers or 
insurance companies, or whether its availability should be regulated by commercial market 
which may explicitly target the higher social classes and incomes to maximize profit. 
Alternatively, the use of  basic PN services may refundable, while specific implementations 
such as comprehensive lifestyle advice(3) may be left to the market. The answer to this issue 
is beyond the scope of the current paper, and should be taken up at the level of policy 
discussion. 
A potential limitation to the current study is the adopted contingent valuation method for 
WTP where participants did not make any actual sacrifice of money(10).  
The proportion of the population and the size of the WTP suggests that there may be a 
market for PN if it can be offered at no more than one and a half time the price of current 
dietary advice services. This suggest that PN may find a place among a minority of the 
European population if it is made available at limited additional cost compared to non-PN 
services, but would be much more likely to be adopted if it is offered through existing health 
care systems at no or very limited extra charge beyond charges in the local health care 
system.  
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Table 1: Average WTP per country per type of required personal information 
Country N 
Reference price 
(local currency) 
Average in % reference 
Lifestyle Lifestyle + Phenotype Lifestyle + Genotype 
Greece 1020 90€ 70.24 75.81 76.64 
Spain 1025 90€ 65.84 68.77 71.21 
Germany
 
1020 100€ 53.38 54.32 54.62 
Ireland 1020 110€ 68.42 69.64 68.44 
Netherlands
 
1020 100€ 42.35 41.70 41.26 
UK
 
1061 ₤80 44.24 47.53 46.65 
Poland
 
1045 230 Złoty 64.50 68.67 70.99 
Norway
 
1022 1100 Norse kroner 52.15 57.23 54.90 
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Table 2:  Distribution of WTP ( (as percentage of reference price) per personalisation level 
 Lifestyle Lifestyle + Phenotype Lifestyle + Genotype 
N 8233  8233  8233  
Nothing 19.6%  19.1%  20.8%  
Lower  
 
51.5%  49.9%  48.4 %  
Mean (SD) 30.10 (21.40) 30.44 (21.66)  30.68 (21.83)  
Median 25.56  26.10  27.27  
Higher 29.0%  31.0%  30.7%  
Mean (SD) 143.84 (62.53)  143.27 (61.14)  146.73 (63.64)  
Median 120.00  119.00  122.23  
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Table 3: Test statistics for effect of sociodemographics on WTP-class membership and mean WTP 
within the Low and the High WTP class  
N=8233
1
 Lifestyle Lifestyle and Blood Lifestyle and DNA 
Country 
(df=14)  
χ
2
=358.82, p<.001,V=.15 χ2=408.11, p<.001,V=.16 χ2=439.02, p<.001,V=.16 
Gender (df=2) χ
2
=29.23 ,p<.001,V=.06 χ2=29.18, p<.001,V=.06 χ2=28.31 ,p<.001,V=.06 
Age class 
(df=6) 
χ
2
=163.34 ,p<.001,V=.10 χ2=173.65, p<.001,V=.10 χ2=159.35 ,p<.001,V=.10 
Education level 
(df=4) 
χ
2
=61.81 ,p<.001,V=.06 χ2=75.02, p<.001,V=.07 χ2=51.54 ,p<.001,V=.06 
Income level 
(df=10)
1 
χ
2
=90.00 ,p<.001,V=.08 χ2=88.96, p<.001,V=.08 χ2=86.65 ,p<.001,V=.08 
 Lower 
(N=360
9) 
(dfe=35
90) 
Higher (N=2269)  
(dfe=2250) 
Lower 
(N=3485)  
(dfe=3466) 
Higher 
(N=2443)  
(dfe=2424) 
Lower 
(N=3393)  
(dfe=3374) 
Higher (N=2415)  
(dfe=2396) 
Country (dfm=7)  F=14.0
2; 
p<.01 
F=5.86; p<.01 F=11.32; 
p<.01 
F=3.92; 
p<.01 
F=2.46; 
p=.02 
F=1.56; p=.14 
Gender (dfm=1) F=6.95; 
p<.01  
F=25.03; p<.01  F=9.97; 
p<.01 
F=15.78; 
p<.01 
F=4.68; 
p=.03 
F=25.85; p<.01 
Age class (dfm=3) F=36.5
4; 
p<.01 
F=1.01; p=.35  F=41.41; 
p<.01 
F=1.80; 
p=.12 
F=34.07; 
p<.01 
F=0.77; p=.51 
Education level 
(dfm=2) 
F=0.63; 
p=.53 
F=0.17; p=.84 F=0.55; 
p=.58 
F=0.33; 
p=.72 
F=0.16; 
p=.86 
F=1.81; p=.17 
Income level 
(dfm=5) 
F=5.97; 
p<.01 
F=5.77; p<.01 F=5.94; 
p<.01 
F=7.04; 
p<.01 
F=4.66; 
p<.01 
F=7.66; p<.01 
1
 Except for income N=7314. Participants not willing or able to disclose income were not included 
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a)  
 
b) 
 
c) 
 
d) 
 
e) 
Figure 1: WTP for different levels of PN by (a) Country (b) Gender (c) Income (d) Age and (e) Education. Bars 
indicate proportion of participants willing to pay: Nothing (dark grey), Lower than reference (mid grey) and Higher 
than reference (light grey). Lines and numbers indicate mean WTP in percentage of the reference. 
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